What are the Challenges in Conducting Clinical Trials for Nanotechnology?
Conducting clinical trials for nanotechnology-based interventions presents unique challenges:
Regulatory hurdles: Nanomaterials often require specialized regulatory pathways due to their unique properties. Standardization: There is a need for standardized protocols to assess and compare the safety and efficacy of different nanomaterials. Complexity: Understanding the complex interactions between nanomaterials and biological systems can be challenging. Cost: Clinical trials, especially those involving novel nanotechnologies, can be expensive and resource-intensive.
